Pulmonary embolism (PE) remains one of the leading causes of maternal mortality. At the French Thoracic Society Spring Days ...

Patients with pulmonary hypertension associated with congenital heart disease make up an increasing proportion of the total pulmonary hypertension population who bring with them added complexity ...

The risk factors for development of fibrotic-like radiographic abnormalities after severe COVID-19 are incompletely described and the extent to which CT findings correlate with symptoms and physical ...

Carried out in collaboration with the Pulmonary Embolism Response Team (PERT) Consortium, the trial enrolled 100 subjects. It aims to offer evidence on the role of CAVT in improving right heart ...

Penumbra has completed subject enrolment in the multi-centre, randomised controlled trial, STORM-PE, which assesses the computer-assisted vacuum thrombectomy (CAVT) using the company’s Lightning Flash ...

Inquis Medical’s AVENTUS Thrombectomy System Receives FDA 510 (k) Clearance for Treatment of Pulmonary Embolism Provided by GlobeNewswire Jun 16, 2025, 6:30:00 AM ...

MENLO PARK, Calif., June 16, 2025 (GLOBE NEWSWIRE) -- Inquis Medical, the leading innovator in the treatment of venous thromboembolic disease, today announced that its AVENTUS Thrombectomy System has ...

PharmTech Group spoke with Andy Burns, vice-president of MDI Business Development at Kindeva, about trends he is observing in the pulmonary drug delivery field as part of our preview of the BIO ...

Objectives This study aim to investigate the incidence, timing and risk factors of metachronous pulmonary recurrence after curative resection in patients with rectal cancer. Design A retrospective ...

A 70-year-old man had an episode of dyspnoea followed by syncope 2 months after a stroke. Deep venous thrombosis was found in his right lower extremity by venous Doppler ultrasound. Transoesophageal ...